HIV / AIDS in the News

Pfizer sells its stake in GSK's ViiV for $1.9B, with Shionogi upping its ante in the HIV-focused company - Fierce Pharma

 

Adolescents report a preference for long-acting injectable HIV therapy - Contemporary Pediatrics

 

The near death -- and last-minute reprieve -- of a trial for an HIV vaccine - wgbh.org

 

Eurasianet: A year on, USAID cuts leave gap in Central Asia’s fight against TB, HIV - European AIDS Treatment Group

 

[Press release] Texas Biomedical Research Institute: TB and HIV treatments are not enough for a full recovery - European AIDS Treatment Group

 

Medscape: Bictegravir combo shows promise in HIV-TB coinfection - European AIDS Treatment Group

 

Pfizer sells ViiV stake to Shionogi - The Pharma Letter

 

CVS Health agrees to cover new HIV prevention drug - Washington Blade

 

ViiV ownership shifts as Pfizer sells its stake - pharmaphorum

 

Iraq blames overseas travel and tattoos for rise in HIV cases - The New Arab

 

HIV-Related Liver Disease: A New Era Emerges - Bioengineer.org

 

HIV Viral Load and Early Infant Treatment Market | Global Industry Analysis & Outlook - 2036 - Fact.MR

 

Florida proposes cutting eligibility for an AIDS drug program, causing panic - statnews.com

 

Pfizer to exit ViiV Healthcare in $1.9 billion deal as Shionogi doubles stake - Reuters

 

Shionogi to Raise Stake in British HIV Drugs Firm ViiV - nippon.com

 

Shionogi to Raise Stake in British HIV Drugs Firm ViiV - nippon.com

 

Japan’s Shionogi boosts ViiV stake in $2.13 billion deal as Pfizer exits - WTVB

 

Shionogi Invests $2.1 Billion to Raise ViiV Healthcare Stake - Bloomberg.com

 

Shionogi Boosts Stake in ViiV Healthcare as Pfizer Exits Joint HIV Venture - TipRanks

 

GSK, Pfizer and Shionogi agree on changes to ViiV Healthcare shareholding - GSK

 

Decoding miRNA-Mediated Immunoregulation in SARS-CoV-2, HBV, HIV, and HSV Infections - Nature

 

One Year Of Trump 2.0: Impact Of Foreign Aid Cuts On Fight Against HIV, TB - NDTV

 

[PODCAST] One year after Trump: The day HIV funding changed forever — and what came next - Bhekisisa

 

Japan's Shionogi to raise stake in UK HIV drugmaker ViiV with $2.1bn investment - MLex

 

Javier Muñoz: Pentagon's message to troops living with HIV is 'rooted in bigotry' - CNN

 

Javier Muñoz: Pentagon's message to troops living with HIV is 'rooted in bigotry' - CNN

 

Ischemic Stroke as the First Manifestation of Primary Antiphospholipid Syndrome in a Patient With a Recent Diagnosis of HIV: A Case Report - Cureus

 

‘I never lacked anything—except answers’ - a young man’s journey of being born with a disease he did not understand - UNAIDS

 

We can block the spread of HIV: Best ideas of the century - New Scientist

 

Scale-up of online HIV and STI self-sampling hasn’t led to more equitable outcomes in England - Aidsmap